Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schoemaker

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
European Journal of Pharmacology|April 20, 1984
Centrally acting drugs alter in vitro beta-endorphin processing in the ratT P Davis, H Schoemaker, A J Culling
European Journal of Pharmacology|October 15, 1984
5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainP E Hicks, H Schoemaker, S Z Langer
Brain Research|January 10, 1983
Effect of chronic ethanol consumption on central and peripheral type benzodiazepine binding sites in the mouse brainH Schoemaker, T L Smith, H I Yamamura
Neuroscience Letters|April 15, 1991
Pharmacological characterisation and autoradiographic distribution of polyamine-sensitive [3H]ifenprodil binding sites in the rat brainC Dana, J Benavides, H Schoemaker, et al.
Peptides|November 1, 1984
Characterization of in vitro proteolytic processing of beta-endorphin by reversed-phase HPLCT P Davis, H Schoemaker, A J Culling-Berglund
Life Sciences|December 29, 1986
Specific regional differences of in vitro beta-endorphin metabolism in schizophrenicsT P Davis, A J Culling-Berglund, H Schoemaker
Brain Research|September 30, 1982
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal gangliaH Schoemaker, M Morelli, P Deshmukh, et al.
Journal of Neurochemistry|July 1, 1985
5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human plateletsA Segonzac, H Schoemaker, T Tateishi, et al.
Psychopharmacology Bulletin|October 1, 1982
A study of the metabolism of des-tyrosine-gamma-endorphin using an improved HPLC systemH Schoemaker, A Chen, T P Davis, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trialJoep H Schoemaker, Wim T Jansen, Jacques Schipper, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Pharmacology|April 20, 1984
Centrally acting drugs alter in vitro beta-endorphin processing in the ratT P Davis, H Schoemaker, A J Culling
European Journal of Pharmacology|October 15, 1984
5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainP E Hicks, H Schoemaker, S Z Langer
Brain Research|January 10, 1983
Effect of chronic ethanol consumption on central and peripheral type benzodiazepine binding sites in the mouse brainH Schoemaker, T L Smith, H I Yamamura
Neuroscience Letters|April 15, 1991
Pharmacological characterisation and autoradiographic distribution of polyamine-sensitive [3H]ifenprodil binding sites in the rat brainC Dana, J Benavides, H Schoemaker, et al.
Peptides|November 1, 1984
Characterization of in vitro proteolytic processing of beta-endorphin by reversed-phase HPLCT P Davis, H Schoemaker, A J Culling-Berglund
Life Sciences|December 29, 1986
Specific regional differences of in vitro beta-endorphin metabolism in schizophrenicsT P Davis, A J Culling-Berglund, H Schoemaker
Brain Research|September 30, 1982
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal gangliaH Schoemaker, M Morelli, P Deshmukh, et al.
Journal of Neurochemistry|July 1, 1985
5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human plateletsA Segonzac, H Schoemaker, T Tateishi, et al.
Psychopharmacology Bulletin|October 1, 1982
A study of the metabolism of des-tyrosine-gamma-endorphin using an improved HPLC systemH Schoemaker, A Chen, T P Davis, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trialJoep H Schoemaker, Wim T Jansen, Jacques Schipper, et al.
Pageof 12